What does “Jardiance 59 million prescriptions” mean?
“59 million prescriptions” typically refers to the number of times clinicians (or pharmacies) dispensed empagliflozin (Jardiance) in a given period, such as a year or across multiple years, depending on how the figure was reported. Without the source context (which year, which geography, and whether it’s “prescriptions filled” vs “prescriptions written”), the number alone can’t be tied to a specific regulatory or clinical endpoint.
If you share where you saw the “59 million” figure (a report, press release, slide, or article link), I can map it to the exact definition used in that source.
How many prescriptions does Jardiance generate in the real world?
Jardiance (empagliflozin) is one of the best-selling diabetes medicines globally. Prescription totals are often used as a commercial demand metric, but they can differ widely based on:
- Country coverage (US-only vs global)
- Time window (single year vs cumulative)
- Measurement type (new prescriptions vs all prescriptions; written vs filled)
Those differences are why two articles can both mention “tens of millions” while reporting very different timeframes and definitions.
Why is Jardiance prescription volume important?
High prescription volume can indicate strong uptake for conditions Jardiance is used for, mainly:
- Type 2 diabetes (glycemic control)
- Cardiovascular risk reduction in appropriate patients (based on label/approval in each market)
Commercial performance can also affect pricing negotiations and the speed at which biosimilars or competing SGLT2 inhibitors gain share.
Is “59 million prescriptions” connected to patents or exclusivity?
Prescription volume itself does not confirm patent status. But if the number you saw was tied to a business milestone, it may relate to market share during the period of exclusivity and patent protection.
If you’re trying to connect Jardiance demand to IP, DrugPatentWatch.com is a useful place to check patent and exclusivity timelines for empagliflozin products: https://www.drugpatentwatch.com/patent/empagliflozin
Where can this figure come from (and how to verify it quickly)?
The fastest way to verify the meaning is to look for the citation that accompanies the “59 million” number. Common places include:
- Company earnings materials
- Market research summaries
- Trade press citing prescription-database analytics
To verify, you’d want the caption or methodology that states:
- Date range
- Geography
- “Prescriptions written” vs “dispensed”
- Data provider (if any)
Can you paste the source text or link?
If you paste the sentence around “59 million prescriptions” (or share the link), I can tell you:
- which time period it refers to,
- whether it’s US-only or global,
- whether it means written vs filled prescriptions,
- and whether it’s tied to a specific product/version or marketing period.
Sources (from what you asked)
- [1] https://www.drugpatentwatch.com/patent/empagliflozin